
07 May 2025
Lower guidance de-risks growth estimates

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Lower guidance de-risks growth estimates
Novo Nordisk A/S Class B (NOVO.B:CSE) | 0 0 0.0%
- Published:
07 May 2025 -
Author:
ABGSC Healthcare Research | Morten Larsen -
Pages:
7 -